nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—AKR1A1—eye—age related macular degeneration	0.0173	0.0616	CbGeAlD
Doxorubicin—AKR1A1—retina—age related macular degeneration	0.0172	0.061	CbGeAlD
Doxorubicin—NDUFS7—connective tissue—age related macular degeneration	0.0152	0.0539	CbGeAlD
Doxorubicin—NOS1—eye—age related macular degeneration	0.0131	0.0466	CbGeAlD
Doxorubicin—NDUFS2—eye—age related macular degeneration	0.0131	0.0464	CbGeAlD
Doxorubicin—NOS1—retina—age related macular degeneration	0.013	0.0462	CbGeAlD
Doxorubicin—NDUFS2—retina—age related macular degeneration	0.0129	0.0459	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—age related macular degeneration	0.0126	0.0447	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—age related macular degeneration	0.0124	0.0441	CbGeAlD
Doxorubicin—DHCR7—retina—age related macular degeneration	0.0122	0.0431	CbGeAlD
Doxorubicin—ABCC6—eye—age related macular degeneration	0.0119	0.0424	CbGeAlD
Doxorubicin—ABCC6—retina—age related macular degeneration	0.0118	0.042	CbGeAlD
Doxorubicin—ABCC6—connective tissue—age related macular degeneration	0.0115	0.0408	CbGeAlD
Doxorubicin—YWHAG—eye—age related macular degeneration	0.0113	0.0399	CbGeAlD
Doxorubicin—YWHAG—retina—age related macular degeneration	0.0111	0.0396	CbGeAlD
Doxorubicin—YWHAG—connective tissue—age related macular degeneration	0.0108	0.0385	CbGeAlD
Doxorubicin—RALBP1—eye—age related macular degeneration	0.0102	0.036	CbGeAlD
Doxorubicin—RALBP1—retina—age related macular degeneration	0.0101	0.0357	CbGeAlD
Doxorubicin—NOS3—connective tissue—age related macular degeneration	0.00963	0.0342	CbGeAlD
Doxorubicin—CBR1—eye—age related macular degeneration	0.00948	0.0337	CbGeAlD
Doxorubicin—NQO1—eye—age related macular degeneration	0.0076	0.027	CbGeAlD
Doxorubicin—NQO1—retina—age related macular degeneration	0.00753	0.0267	CbGeAlD
Doxorubicin—NQO1—connective tissue—age related macular degeneration	0.00732	0.026	CbGeAlD
Doxorubicin—CYP1B1—eye—age related macular degeneration	0.00534	0.0189	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—age related macular degeneration	0.00514	0.0182	CbGeAlD
Doxorubicin—ABCB1—retina—age related macular degeneration	0.00194	0.00689	CbGeAlD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00111	0.00155	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—SLC16A8—age related macular degeneration	0.0011	0.00153	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—KDR—age related macular degeneration	0.00109	0.00151	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ABCA4—age related macular degeneration	0.00107	0.00149	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NMNAT1—age related macular degeneration	0.00105	0.00146	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RDH8—age related macular degeneration	0.00105	0.00146	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—VEGFA—age related macular degeneration	0.00103	0.00144	CbGpPWpGaD
Doxorubicin—NOS2—Disease—RPE65—age related macular degeneration	0.001	0.00139	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000977	0.00136	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—SQSTM1—age related macular degeneration	0.000954	0.00133	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ABCA4—age related macular degeneration	0.000937	0.0013	CbGpPWpGaD
Doxorubicin—NOS1—Disease—RHO—age related macular degeneration	0.00093	0.0013	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RPE65—age related macular degeneration	0.000919	0.00128	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NMNAT1—age related macular degeneration	0.000913	0.00127	CbGpPWpGaD
Doxorubicin—CYP2D6—Melatonin metabolism and effects—APOE—age related macular degeneration	0.000911	0.00127	CbGpPWpGaD
Doxorubicin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—age related macular degeneration	0.000911	0.00127	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00089	0.00124	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NMNAT1—age related macular degeneration	0.000889	0.00124	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RDH8—age related macular degeneration	0.000889	0.00124	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NMNAT1—age related macular degeneration	0.000881	0.00123	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000871	0.00121	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000871	0.00121	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000861	0.0012	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—age related macular degeneration	0.00085	0.00118	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NMNAT1—age related macular degeneration	0.000819	0.00114	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RHO—age related macular degeneration	0.000815	0.00113	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ABCA4—age related macular degeneration	0.000806	0.00112	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.000799	0.00111	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ELOVL4—age related macular degeneration	0.000798	0.00111	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000787	0.0011	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RPE65—age related macular degeneration	0.000777	0.00108	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000775	0.00108	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ELOVL4—age related macular degeneration	0.00077	0.00107	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000765	0.00107	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—LIPC—age related macular degeneration	0.000757	0.00105	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—LIPC—age related macular degeneration	0.000757	0.00105	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—NMNAT1—age related macular degeneration	0.000744	0.00104	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ABCA4—age related macular degeneration	0.000741	0.00103	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RDH8—age related macular degeneration	0.000737	0.00103	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000734	0.00102	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000734	0.00102	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CETP—age related macular degeneration	0.00073	0.00102	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CETP—age related macular degeneration	0.00073	0.00102	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ELOVL4—age related macular degeneration	0.000716	0.000997	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000713	0.000993	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—LIPC—age related macular degeneration	0.000711	0.00099	CbGpPWpGaD
Doxorubicin—NOS2—Disease—RHO—age related macular degeneration	0.000702	0.000977	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000695	0.000967	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00069	0.000961	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00069	0.000961	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000688	0.000958	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CETP—age related macular degeneration	0.000686	0.000956	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000682	0.00095	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000682	0.00095	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000674	0.000938	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—CD36—age related macular degeneration	0.000656	0.000913	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ELOVL4—age related macular degeneration	0.000651	0.000906	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000648	0.000902	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RHO—age related macular degeneration	0.000645	0.000898	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RPE65—age related macular degeneration	0.000644	0.000896	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—SLC16A8—age related macular degeneration	0.000643	0.000896	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.000634	0.000882	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ABCA4—age related macular degeneration	0.000626	0.000872	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RDH8—age related macular degeneration	0.000622	0.000867	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SLC16A8—age related macular degeneration	0.000621	0.000864	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—LIPC—age related macular degeneration	0.000605	0.000842	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NMNAT1—age related macular degeneration	0.000604	0.000841	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0006	0.000836	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0006	0.000836	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—VEGFA—age related macular degeneration	0.000598	0.000833	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00059	0.000821	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CETP—age related macular degeneration	0.000584	0.000813	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CST3—age related macular degeneration	0.000582	0.00081	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NMNAT1—age related macular degeneration	0.000579	0.000806	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SLC16A8—age related macular degeneration	0.000577	0.000803	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—LIPC—age related macular degeneration	0.000564	0.000785	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RHO—age related macular degeneration	0.000545	0.000759	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CETP—age related macular degeneration	0.000544	0.000758	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RPE65—age related macular degeneration	0.000544	0.000757	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RDH8—age related macular degeneration	0.000542	0.000754	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NMNAT1—age related macular degeneration	0.000542	0.000754	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ELOVL4—age related macular degeneration	0.000528	0.000735	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SLC16A8—age related macular degeneration	0.000524	0.00073	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFBR1—age related macular degeneration	0.000522	0.000727	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ABCA4—age related macular degeneration	0.000519	0.000723	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ELOVL4—age related macular degeneration	0.000506	0.000704	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.0005	0.000696	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—CD36—age related macular degeneration	0.000494	0.000688	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000489	0.000681	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RPE65—age related macular degeneration	0.000473	0.000659	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000472	0.000657	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000469	0.000653	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.000466	0.000649	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000457	0.000637	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NMNAT1—age related macular degeneration	0.000454	0.000632	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000452	0.00063	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RHO—age related macular degeneration	0.000451	0.000629	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000445	0.000619	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CD36—age related macular degeneration	0.000439	0.000611	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CD36—age related macular degeneration	0.000439	0.000611	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NMNAT1—age related macular degeneration	0.000439	0.000611	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CST3—age related macular degeneration	0.000439	0.000611	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ABCA4—age related macular degeneration	0.000438	0.000611	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00043	0.000599	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC16A8—age related macular degeneration	0.000425	0.000592	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000415	0.000577	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000414	0.000576	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CD36—age related macular degeneration	0.000412	0.000574	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC16A8—age related macular degeneration	0.000408	0.000568	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CST3—age related macular degeneration	0.000403	0.000561	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000399	0.000556	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NMNAT1—age related macular degeneration	0.000399	0.000556	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ELOVL4—age related macular degeneration	0.000396	0.000552	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFBR1—age related macular degeneration	0.000394	0.000548	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—APOE—age related macular degeneration	0.000387	0.000539	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—APOE—age related macular degeneration	0.000387	0.000539	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—CD36—age related macular degeneration	0.000384	0.000535	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ELOVL4—age related macular degeneration	0.000383	0.000534	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ABCA4—age related macular degeneration	0.000382	0.000531	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RHO—age related macular degeneration	0.000381	0.000531	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000367	0.000511	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000365	0.000508	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000364	0.000507	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—APOE—age related macular degeneration	0.000364	0.000507	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFBR1—age related macular degeneration	0.000362	0.000504	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000355	0.000495	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000354	0.000493	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000351	0.000489	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CD36—age related macular degeneration	0.000351	0.000488	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ELOVL4—age related macular degeneration	0.000349	0.000486	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000343	0.000477	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000341	0.000475	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CST3—age related macular degeneration	0.000341	0.000474	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000337	0.000469	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RHO—age related macular degeneration	0.000332	0.000462	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—LIPC—age related macular degeneration	0.000329	0.000459	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CD36—age related macular degeneration	0.000327	0.000455	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000325	0.000452	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000325	0.000452	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC16A8—age related macular degeneration	0.00032	0.000445	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—LIPC—age related macular degeneration	0.000318	0.000442	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CETP—age related macular degeneration	0.000318	0.000442	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—VEGFA—age related macular degeneration	0.000312	0.000435	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—APOE—age related macular degeneration	0.000309	0.000431	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC16A8—age related macular degeneration	0.000309	0.00043	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CETP—age related macular degeneration	0.000307	0.000427	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFBR1—age related macular degeneration	0.000306	0.000426	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000297	0.000413	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—LIPC—age related macular degeneration	0.000295	0.000411	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NMNAT1—age related macular degeneration	0.000293	0.000407	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—APOE—age related macular degeneration	0.000289	0.000402	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CETP—age related macular degeneration	0.000285	0.000397	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000284	0.000395	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.000281	0.000392	CbGpPWpGaD
Doxorubicin—NOS1—Disease—APOE—age related macular degeneration	0.00028	0.00039	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000272	0.000378	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00027	0.000376	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—LIPC—age related macular degeneration	0.000268	0.000374	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—C3—age related macular degeneration	0.000263	0.000367	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CETP—age related macular degeneration	0.000259	0.000361	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ELOVL4—age related macular degeneration	0.000256	0.000356	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000253	0.000353	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00025	0.000348	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—APOE—age related macular degeneration	0.000245	0.000341	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KDR—age related macular degeneration	0.00024	0.000335	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00024	0.000334	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—VEGFA—age related macular degeneration	0.000235	0.000328	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000234	0.000326	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SQSTM1—age related macular degeneration	0.00023	0.00032	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—LIPC—age related macular degeneration	0.000218	0.000303	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000216	0.0003	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000214	0.000298	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000213	0.000297	CbGpPWpGaD
Doxorubicin—NOS2—Disease—APOE—age related macular degeneration	0.000211	0.000294	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CETP—age related macular degeneration	0.00021	0.000293	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—LIPC—age related macular degeneration	0.000209	0.000291	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CST3—age related macular degeneration	0.000208	0.000289	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCL2—age related macular degeneration	0.000206	0.000287	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC16A8—age related macular degeneration	0.000206	0.000287	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000206	0.000287	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000203	0.000283	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CETP—age related macular degeneration	0.000201	0.00028	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000194	0.00027	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—APOE—age related macular degeneration	0.000194	0.00027	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CD36—age related macular degeneration	0.000191	0.000266	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000189	0.000263	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000188	0.000262	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFBR1—age related macular degeneration	0.000186	0.000259	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CD36—age related macular degeneration	0.000184	0.000257	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—VEGFA—age related macular degeneration	0.000183	0.000255	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000182	0.000253	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000178	0.000247	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CD36—age related macular degeneration	0.000171	0.000238	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—APOE—age related macular degeneration	0.000168	0.000235	CbGpPWpGaD
Doxorubicin—NOS3—Disease—APOE—age related macular degeneration	0.000164	0.000228	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LIPC—age related macular degeneration	0.000164	0.000228	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—APOE—age related macular degeneration	0.000163	0.000226	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00016	0.000223	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LIPC—age related macular degeneration	0.000158	0.00022	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CETP—age related macular degeneration	0.000158	0.00022	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CD36—age related macular degeneration	0.000156	0.000217	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CETP—age related macular degeneration	0.000153	0.000213	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000152	0.000212	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—APOE—age related macular degeneration	0.000151	0.00021	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—C3—age related macular degeneration	0.000146	0.000203	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LIPC—age related macular degeneration	0.000144	0.0002	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000143	0.000199	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CETP—age related macular degeneration	0.000139	0.000193	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—APOE—age related macular degeneration	0.000137	0.000191	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—APOE—age related macular degeneration	0.000136	0.000189	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KDR—age related macular degeneration	0.000133	0.000185	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000133	0.000185	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—age related macular degeneration	0.000132	0.000184	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CD36—age related macular degeneration	0.000126	0.000176	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—C3—age related macular degeneration	0.000123	0.000172	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CD36—age related macular degeneration	0.000121	0.000169	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000116	0.000162	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000116	0.000161	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOE—age related macular degeneration	0.000115	0.00016	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—age related macular degeneration	0.000114	0.000159	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KDR—age related macular degeneration	0.000112	0.000157	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOE—age related macular degeneration	0.000111	0.000155	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—age related macular degeneration	0.000107	0.000149	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LIPC—age related macular degeneration	0.000106	0.000147	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CETP—age related macular degeneration	0.000102	0.000142	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—age related macular degeneration	9.99e-05	0.000139	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—age related macular degeneration	9.65e-05	0.000134	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CD36—age related macular degeneration	9.48e-05	0.000132	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	9.37e-05	0.00013	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CD36—age related macular degeneration	9.17e-05	0.000128	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—age related macular degeneration	8.37e-05	0.000117	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CD36—age related macular degeneration	8.35e-05	0.000116	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—age related macular degeneration	8.09e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LIPC—age related macular degeneration	7.78e-05	0.000108	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CETP—age related macular degeneration	7.51e-05	0.000105	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—age related macular degeneration	7.36e-05	0.000103	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—age related macular degeneration	7.33e-05	0.000102	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LIPC—age related macular degeneration	7.33e-05	0.000102	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CETP—age related macular degeneration	7.08e-05	9.85e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—age related macular degeneration	6.2e-05	8.63e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CD36—age related macular degeneration	6.12e-05	8.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—age related macular degeneration	5.4e-05	7.52e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LIPC—age related macular degeneration	4.79e-05	6.68e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CETP—age related macular degeneration	4.63e-05	6.44e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CD36—age related macular degeneration	4.51e-05	6.28e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CD36—age related macular degeneration	4.25e-05	5.92e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—age related macular degeneration	3.98e-05	5.54e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—age related macular degeneration	3.75e-05	5.22e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CD36—age related macular degeneration	2.78e-05	3.87e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—age related macular degeneration	2.45e-05	3.42e-05	CbGpPWpGaD
